Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ski2-like RNA helicase (SKIC2) is a cytoplasmic RNA helicase belonging to the DExH-box family, serving as a core component of the SKI complex, which collaborates with the cytoplasmic exosome to facilitate turnover and quality control of mRNAs[1][2][3]. SKIC2 is highly conserved across eukaryotes and is implicated in the extraction and degradation of aberrant or excess mRNA via 3'-to-5' decay by unwinding RNA substrates and channeling them to the exosome[1][2]. In humans, loss-of-function variants in SKIC2 cause trichohepatoenteric syndrome, a rare disorder affecting multiple organs, presumably by impairing cellular RNA quality control pathways[3]. This protein may also have a role in cellular antiviral defense by targeting viral RNAs for degradation[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ski2-like RNA helicase (SKIC2).